Effects Of Intranodal Autologous Tumor Lysate-DC Vaccine With Aldesleukin (IL-2) And IFN-alpha2a In Metastatic Renal Cell Carcinoma Patients
Links shared publicly online about this topic.
- 1,562total visits
Effects Of Intranodal Autologous Tumor Lysate-DC Vaccine With Aldesleukin (IL-2) And IFN-alpha2a In Metastatic Renal Cell Carcinoma Patients
UroToday.com - Immunotherapy with interleukin 2 (IL-2) for metastatic renal cancer continues to offer a minority of patients the potential of durable complete responses without additional treatme
View full resource at medicalnewstoday.com
Tags: Vaccination, Cancer, Renal Cell Carcinoma, Kidney Health, Urinary System, Vaccine
Most Recently Shared on December 1, 2009 at 6:41 pm By:
Effects Of Intranodal Autologous Tumor Lysate-DC Vaccine With Aldesleukin (IL-2) And IFN-alpha2a In Metastatic Rena... http://ow.ly/165KBp
Advertisement
